Guerbet: First-half 2023 revenue
First-half 2023 revenue ...…
36,500€
Echtzeit-Aktienkurs Guerbet S.A.
Bid:
Ask:
Nachrichten zur Guerbet S.A. Aktie
Guerbet: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer
Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer...…
Guerbet: Guerbet strengthens its Executive Committee with two new appointments to accelerate its commercial and industrial development
Guerbet strengthens its Executive Committee with two new appointments to accelerate its commercial and industrial development...…
XFRA : DIVIDEND/INTEREST INFORMATION - 29.06.2023 - FR0000032526
Das Instrument 4G8 FR0000032526 GUERBET SA INH. EO 1 EQUITY wird ex Dividende/Zinsen gehandelt am…
Guerbet: Q1 2023 Revenue
Q1 2023 RevenueQuarterly activity...…
Guerbet: 2022 annual results
2022 annual results...…
Guerbet Announces Commercial Launch and First Patient Dosing of Elucirem™ (Gadopiclenol) Injection, a Novel New Macrocyclic GBCA for Use in Contrast-Enhanced Magnetic Resonance Imaging (MRI)
First dosage administered at the Hospital of the University of Pennsylvania following FDA approval Elucirem™ has the highest relaxivity compared…
Guerbet: 2022 revenue
2022 revenue...…
Guerbet: 2023 Strategic Priorities
2023 Strategic Priorities...…
Guerbet: Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions
Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under…
Guerbet to Spotlight the Novel New Drug Elucirem™ (gadopiclenol) injection at the 2022 Radiological Society of North America Scientific Assembly and Annual Meeting
Join us at Booth #1711 Opportunity to learn about the recently US FDA-approved novel new drug, Elucirem™ Announcing Guerbet Research…
Guerbet: Guerbet announces a change in governance for its Artificial Intelligence projects
Guerbet announces a change in governance for its Artificial Intelligence projects...…
Guerbet: Revenue at September 30, 2022
Revenue on September 30, 2022...…